• 12-13 September 2016

    2016 PACT REGIONAL CONFERENCE: Cooperation within the Region: A Way to Improve Access to Quality Healthcare in CEE

    SHARE THIS EVENT:   

  • 12-13 September 2016

    2016 PACT REGIONAL CONFERENCE

    Join us for an inspiring 2-day event to discuss with key opinion leaders and health stakeholders how to improve access to quality healthcare in the countries from Central and Eastern Europe!

    SHARE THIS EVENT:   

  • 12-13 September 2016

    2016 PACT REGIONAL CONFERENCE

    More than 150 patients, medical and public health experts, industry partners as well as key national and EU officials at one place! Be one of them!

    SHARE THIS EVENT:   

EVENT WILL START IN

2016-09-12 08:00:00 2016-09-13 13:00:00 Europe/Sofia 2016 PACT REGIONAL CONFERENCE 2016 PACT REGIONAL CONFERENCE: Cooperation within the Region: A Way to Improve Access to Quality Healthcare in CEE Sofia, Bulgaria, Hotel Marinela Patience Access Partnership [email protected]

ABOUT PACT

The Patient Access Partnership is a patient-led multi-stakeholder network bringing together patients, the medical and public health community, industry and the European and member states policy makers and institutions, in order to develop and move forward on innovative solutions to reduce inequities in access to quality healthcare in the European Union.

Vision

The patient access partnership enables different health stakeholders to join forces to develop, drive and propose to the EC and the Member States sustainable solutions to ensure equitable patient access to quality healthcare in the EU. Stakeholders will actively participate in delivering these solutions.

Mission

The activities of the patient access partnership are patient-focused. Information and knowledge transfer are a key requirement to identify gaps in and measure access to quality healthcare between and within member states. The Partnership will develop a tool to monitor and measure equity of access in member states on an on-going basis. Through holistic collaboration with relevant EU-led or national initiatives, the Partnership will provide a much needed space for creativity, coherence and collaboration and propose sustainable solutions.

Objectives

  • To facilitate the dialogue between European and national health stakeholders according to the mission
  • To identify key hurdles in access to healthcare for patients in a holistic way
  • To assess gaps in access to quality healthcare within EU member states
  • To collaborate with relevant EU-led or national initiatives
  • To develop innovative and sustainable solutions

THE “5As” OF ACCESS

The partners of PACT agreed on key principles supporting the notion of access: Availability, Adequacy, Accessibility, Affordability and Appropriateness, or in short – the “5As” principles.

The 5As principle stands for:

Availability

Whether services are available in the first place.

Adequacy

Whether there is an adequate and continued supply of available services.

Accessibility

Whether the services are effectively available for utilization. Access measured in terms of utilization is dependent on the physical accessibility and acceptability of services and not merely adequacy of supply. This can also refer to the time to get necessary healthcare, for example.

Affordability

A system for financing health services so people do not suffer financial hardship when using them.

Appropriateness

Services available must be relevant to the different parts of a population in terms of their health needs and material and cultural settings if the population is to ′gain access to satisfactory health outcomes′. In other words, available health care resources should meet the needs of different population groups.

MEP INTEREST GROUP ON ACCESS

The Members of the European Parliament (MEP) Interest Group on Patient Access to Healthcare is an informal group of MEPs committed to improve access to healthcare in Europe.

Objectives:

Access on the agenda

To bridge healthcare stakeholders and EU policy-making, i.e. will be the political arm of the PACT - thus providing a forum for debate and action on equal access to healthcare to ensure that this issue features on the EU policy agenda

Work with institutions

To actively work with the European Commission and the Council to identify the possible EU policy measures aimed at improving access (within the currently limited powers that the EU institutions have in the field of healthcare policy) - mapping barriers and gaps in access across the EU28 (PACT′s work stream 1) is one of the actions that the European Commission has the power and the commitment to do, and political support (from the IG) for this exercise is more than necessary

Bridge policies

To work with the Council to make sure that EU policy measures are tailor-made to respect specific national problems and that Member States respond positively to EU-suggested initiatives. The supporting MEPs will promote in their Member States the opportunities created by the EU for healthcare-related projects at Member States′ level.

Promote the multi-stakeholder approach

The supporting MEPs will advocate the model of partnership shared by the PACT and the IG, at Member States′ level



CONFERENCE

What is PACT Regional Conference?

The Conference “Cooperation within the Region: A Way to Improve Access to Quality Healthcare in CEE” is a conference of the Patient Access Partnership on Equity of Access to Quality Healthcare (PACT), organised by the National Patients’ Organisation – Bulgaria in cooperation with the Ministry of Health of the Republic of Bulgaria and the European Patients’ Forum (EPF). The two-day event will be held on 12-13 September in Sofia, welcoming PACT affiliates from the countries in the CEE region (Bulgaria, Croatia, the Czech Republic, Hungary, Poland, Romania, the Slovak Republic, Slovenia, and the three Baltic States: Estonia, Latvia and Lithuania, including Greece, Macedonia, Serbia and Turkey).

Why now?

Ensuring access to quality healthcare across the EU Member States by tackling health inequalities has been a key concern for the past several years, which has attracted significant attention both at EU and local levels. More specifically, the issue was notably raised by patient organisations back in 2012 with the First Conference on Health Inequalities in the EU Member States (Bulgaria), followed by a number of emblematic high-level political decisions including the Lithuanian EU Presidency Conference on Sustainable Health Systems – Vilnius Declaration (2013), Commission Communication on Effective, Accessible and Resilient Health Systems (2014), Council Conclusions on the Economic Crisis and Impact on Health (2014), Council Conclusions New medicines for the benefit of patients (2014), Latvian EU Conference on Universal Health – RIGA roadmap (2015) and the Sustainable Development Goals (2015).

Amidst and in line with these developments, the Patient Access Partnership was formed - a patient-led multi-stakeholder network bringing together patients, the medical and public health community, industry and the EU and Member States policy-makers and institutions in order to develop and move forward on innovative solutions to reduce inequities in access to quality healthcare in the EU. In view of the significant challenges ahead, the Patient Access Partnership is determined to play a key role in contributing further to the efforts of improving access to healthcare.

Why is it important?

The Conference offers a timely opportunity for the regional healthcare community to re-affirm its political commitment to address the gaps in access to healthcare by discussing potential measures and innovative instruments for further actions.

The focus of the Conference will be provided by discussions on best practices and cooperation opportunities at regional and nation level, the implications and significance of the EU Semester, the opportunities that the EU structural funds provide as well as the added value and the practical implications of the UN Sustainable Development Goals.

What do we aim for?

  • Discuss the barriers to ensuring equal access to quality healthcare in CEE countries;
  • Encourage informative discussion on the existing sustainable mechanisms for improving healthcare systems, including actions in line with the recommendations set forward in the Sustainable Development Goals;
  • Increase cooperation between policy-makers and stakeholders within and between the countries from the region;
  • Raise awareness on the added value of existing best-practice examples of cooperation between stakeholders for improving access to healthcare and encouraging cooperation in neighbouring countries;
  • Provide recommendations on follow-up actions to ensure better access to quality health services in the region

AGENDA

  • James Bourchier Boulevard 100
    Hotel Marinela, 1407 Sofia

  • Sept 12 - 13, 2016
    08:00 AM - 13:00 PM

  • 150 Seats Available
    Hurry up! Book your seat

  • 8:00 AM - 9:00 AM

    REGISTRATION

  • 9:00 AM - 10:30 AM

    ROOM "Sofia Grand"

    I. Setting the scene: health at the heart of sustainable development.

    The session will delineate major public health challenges from a policy perspective that the EU faces in the last decade and efforts to address these issues.

    Questions: What are the major public health challenges that the EU faces in the last decade? What are the key trends for improving health care management at the EU level? What are the opportunities for action in line with the recommendations of the Riga Roadmap?

    Speakers:

    • Dr. Petre Moskov, Minister of Health of the Republic of Bulgaria
    • Mr. Stanimir Hasardzhiev, MD, Secretary-General, Patient Access Partnership
    • Mr. Andrey Kovatchev MEP, Group of the European People's Party
    • Mr. Šarūnas Narbutas, President of “Lithuanian Cancer Patient Coalition” (POLA) and Adviser to the President of the Republic of Lithuania
    • Ms. Alyna C. Smith, Advocacy Officer – Health, Legal Strategies and Women, Platform for International Cooperation on Undocumented Migrants (PICUM)


    Q&A

  • 10:30 AM - 11:30 AM

    ROOM "Sofia Grand"

    II. The state of play: measuring progress on EU actions to improve access.

    The session will provide data on access to healthcare in the CEE countries.

    Questions: What is the situation on the ground in the CEE countries? How far are we in terms of implementation of policies which aim to improve access? What are the key challenges in access that need to be addressed?

    Speakers:

    • Mr. Jan De Maeseneer M.D., PhD., (Hon) FRCGP, Vice-dean for strategic planning at the Faculty of Medicine and Health Sciences at Ghent University (Belgium) / Chairperson of the (former) Expert Panel on effective ways of investing in Health (EXPH)
    • Mr. Yannis Natsis, Policy Coordinator Universal Access and Affordable Medicines, EPHA

    Q&A

  • 11:30 AM - 12:00 AM

    COFFEE BREAK

  • 12:00 AM - 1:30 PM

    ROOM "Sofia Grand"

    III. How to improve access through cooperation? Best-practice examples.

    The session will provide an opportunity for presentation of good and bad practice examples of cooperation from the region.

    Questions: What examples of successful / unsuccessful models for cooperation exist? Can multi-stakeholder platforms help to improve health systems performance? What potential challenges may hinder these efforts? What was the critical success factor?

    Presentations:

    • “New voluntary collaborations on pharmaceutical policy: Belgium-Netherlands-Luxembourg-Austria take the initiative”, Marc Van de Casteele, MD PhD Coordinator of pharmaceutical assessment, Belgian Institute for Health Insurance and Invalidity
    • Access to Essential Medicines for Greater Health Outcome”, Prof. Zoltán Kaló Professor of Health Economics, Eötvös Loránd University (ELTE) / Syreon Research Institute
    • “How can Pragmatic Value Assessment (PrVA) benefit countries of the Central European region?”, Dr. Dávid Dankó, PhD, Managing Director, Ideas & Solutions
    • “Improving access to health services for Roma and other vulnerable groups: the development of EU Roma Health Mediation Network”, Ms. Mariya Samuilova, Project officer, Migration Health Division, International Organization for Migration
    • “Optimal treatment for all: European challenges and the way forward”, Mr. Denis Horgan, Executive Director, European Alliance for Personalised Medicine
    • Q&A

    Posters:

    • “Access to healthcare for migrants in the Czech Republic”, Ms. Elena Tulupova
    • “Hindering Access to Treatment by Ill-devised cost-containment measures – Romanian experience”, Dr. Laurentiu Mihai
    • “Health Inequalities in Europe”, Mr. Lucian-Andrei Despa
    • “The relationship between occupational stress and the need for psychological primary help for medical personnel in Romania. Implications for the quality of life.”, Ms. Violeta Rotarescu
    • “Supportive Counselling for the Cancer Patients and Kins at the Pharmacy”, Ms. Seda Kansu
  • 1:30 PM - 2:30 PM

    LUNCH

  • 2:30 AM - 3:30 PM

    ROOM "Sofia Grand"

    IV. Improving access: existing and potential EU mechanisms

    The session will provide information on the EU Semester, the EU Structural Funds and the Investment Plan for Europe as mechanisms to support national efforts to improve access.

    Questions: What is the relevance, applicability and added value of the European Semester as an assessment mechanism for health systems performance? What funding opportunities do EU Structural and Investment Funds and the Investment Plan for Europe provide to improve health systems in the EU? What other possibilities exist?

    Presentation:

    • Mr. Artur Carvalho, European Commission, DG Health and Food Safety, Unit B1- Performance of national health systems

    Country examples:

    Q&A

  • 3:30 PM - 4:00 PM

    COFFEE BREAK

  • 4:00 PM - 5:30 PM

    ROOM "Sofia Grand"

    V. Improving access in practice.

    Workshop: Roundtable discussions on possible actions to improve access through cooperation.

    The representatives from each category gather by country (Bulgaria, Croatia, the Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia, Estonia, Latvia and Lithuania, including Greece, Macedonia, Serbia and Turkey).

    Questions: What are the strengths and weaknesses of these tools? How applicable are they in your country? What are the major challenges and opportunities in using them?

    Task:
    Please identify 3 key recommendations on:

    • ✔ Better use of the EU Semester as a mechanism to support health reforms at the national level
    • ✔ Improving the implementation of EU Structural Funds to better meet the needs of the Member States
    • ✔ Improving the cooperation between stakeholders at the national and international levels
  • 5:30 PM - 6:00 PM

    VI. Rapporteurs’ workshop

    Moderator: Mr. Stanimir Hasardzhiev

  • 8:00 PM

    DINNER

ABSTRACTS

One of the main objectives of the PACT Regional Conference is to encourage informative discussion on the existing sustainable mechanisms for improving healthcare systems. For this reason, PACT announced an Open Call for Abstracts.


Abstracts submitted were relevant to the following topic: “How to improve access through cooperation? Best-practice examples.”

The selected abstracts were examples of successful national models for cooperation. More specifically, they address the following questions:

  1. Can multi-stakeholder platforms help to improve health systems performance?
  2. What potential challenges may hinder these efforts?
  3. What was the critical success factor?

The conference committee reviewed the submitted abstracts and selected abstracts within two categories: plenary presentations and posters.


SPEAKERS

Petre Moskov

Petre Moskov

Minister of Health of Republic of Bulgaria

Petre Moskov was born on December 17, 1970 in Sofia.

He graduated from Sofia Medical University with a specialty in Anesthesiology and Intensive Care. He has completed residency trainings in France, UK, Spain and USA.

Since 1994 he has been senior assistant at the Clinic for Anesthesiology and Intensive Care, St. Sofia University Multiprofile Hospital for Active Treatment, in Sofia.

In 2013 he was elected Deputy Chairman of Democrats for Strong Bulgaria political party.

He was elected Minister of Health of November 7, 2014 by the 43rd National Assembly.
Stanimir Hasurdjiev

Stanimir Hasurdjiev

Chairperson of the Bulgarian National Patients’ Organization (NPO)

Dr. Stanimir Hasurdjiev is one of the founders and current Chairperson of the Bulgarian National Patients’ Organization (NPO) – the biggest patients’ umbrella organization in Bulgaria. By 2015 the membership of NPO accounts to around 80 disease-specific member organizations representing patients with different socially significant diseases in all 28 regions in Bulgaria.

Dr. Hasurdjiev has devoted himself to the work in the patients’ advocacy sector and in defense of patients’ rights. In 2011 and 2015, he represented the Bulgarian patients in the Supervisory Board of the National Health Insurance Fund.

As of May 2013, Dr. Hasurdjiev is a board member of the European Patients’ Forum as well as a member of several regional and international organizations and networks, e.g. World Hepatitis Alliance, European Community Advisory Board, International Capacity Building Alliance and others.

In addition, he is one of the initiators and founders of the joint initiative of the European Patients’ Forum and the Bulgarian National Patients’ Organization – the Patient Access Partnership (PACT) – a multi stakeholder platform for finding innovative solutions to reduce inequities in access to healthcare in Europe, where Stanimir takes the position of a Secretary-General.

Dr. Hasurdjiev serves as a Secretary of the initiative "Health Partnership" which was officially launched in March 2015 as a permanent consultative body to the Council of Ministers. The initiative is part of the "Objectives for Health 2020" paper by the Bulgarian Ministry of Health and follows the model of the European Patient Access Partnership platform, incorporating representatives of the patient organizations, governmental institutions, unions of medical practitioners, hospitals, industry and providers of health care services, appliances and facilities. The active Minister of Health in Bulgaria serves as the Chairperson of the new platform.

Stanimir Hasurdjiev has many Bulgarian and international awards, such as the Best Media Award for the World Hepatitis Day campaign in 2008 “Am I number 12”. In 2011 National Patients’ Organization was awarded a prize by Effie Worldwide Awards for its campaign “If the healthcare system doesn’t hear you”.
Dr. Andrey Kovatchev

Dr. Andrey Kovatchev

Member of the Presidency of the European Parliament (Quaestor)

Dr. Andrey Kovatchev is a Member of the Presidency of the European Parliament (Quaestor) as well as the Committee on Foreign Affairs and the Delegation for Relations with the US. He is a substitute member of the Committee on the Environment, Public Health and Food Safety and the Delegation to the EU-Former Yugoslav Republic of Macedonia Joint Parliamentary Committee. Since 2011 he is the Vice-President of the Union of European Federalists and is also president of the Bulgarian section of the organization. In the current term Dr. Kovatchev initiated an informal Interest Group on Access to Healthcare in the European Parliament that provides a forum for action and debate on equal access to healthcare and ensures that the issue features on the EU policy agenda. He earned a degree from the University of Saarland Germany and a holds a PhD in Natural Sciences.
Šarūnas Narbutas

Šarūnas Narbutas

Adviser to the President of the Republic of Lithuania

Šarūnas Narbutas is a professional lawyer and an Adviser to the President of the Republic of Lithuania on legal affairs, who was diagnosed with chronic myelogenous leukemia (CML) at the age of 18. After hearing the diagnosis he has started a national petition campaigning for successful treatment for CML patients, which was signed by 6% of the total Lithuanian population (180,000 signatures) and has led to doubled reimbursement for modern treatment. In 2010-2013 he served as a Board member of “European Cancer Patient Coalition” (ECPC).

In the past 5 years, he has participated as a patient advocate speaker / moderator in over 50 high-level conferences throughout Europe and on an international scale and has led a debate on cancer-related issues at the national level and in front of European authorities. Since 2013 he is acting as a President of “Lithuanian Cancer Patient Coalition” (POLA).

Before joining the President’s team Šarūnas Narbutas has also served as a member of an advisory board to the Minister of Health of the Republic of Lithuania, as a member of a Lithuanian reimbursement committee and also as a deputy chair of the commission awarding damages to patients caused by a medical mal-practice, while also representing interest of cancer patients in dozens of governmental working groups. He is also a PhD candidate in Vilnius University Faculty of Law and reads lectures on Health Law, European Union Law and Public International Law.
Alyna C. Smith

Alyna C. Smith

Advocacy Officer, PICUM (Platform of International Cooperation on Undocumented Migrants)

Advocacy Officer, PICUM (Platform of International Cooperation on Undocumented Migrants)

Ms Smith is Advocacy Officer at PICUM, where she leads their work on access to health care and access to justice. Established in 2001, PICUM is a network of more than 150 organisations across 38 countries working to advance the rights of undocumented migrants. Before joining PICUM, Alyna was a litigation associate at a global law firm in New York where she developed an extensive pro bono practice in the areas of criminal justice, immigration law and human rights. Her prior work experience includes a clerkship with Canada’s Federal Court, and work on ethics, genetics and access to medicines for the World Health Organization. Alyna holds a bachelor’s degree in human biology and ethics, a master’s degree in philosophy, and a degree in law from the University of Toronto.
Prof. Jan De Maeseneer M.D., PhD., (Hon) FRCGP.

Prof. Jan De Maeseneer M.D., PhD., (Hon) FRCGP.

Vice-dean for strategic planning at the Faculty of Medicine and Health Sciences

Jan De Maeseneer (°1952, Gent) graduated as a Medical Doctor in 1977 at Ghent University (Belgium). Since 1978, he has been working part-time as a family physician in the community health centre Botermarkt in Ledeberg, a deprived area in the city of Ghent. From 1978 to 1981, he worked as a part-time research-assistant in health promotion at the Department of Public Health (Prof. Dr. K. Vuylsteek). Since 1981, he has been working as a part-time assistant at the Department of Family Medicine and since 1991, he chairs the department. Since 1.10.2008 he is the vice-dean for strategic planning at the Faculty of Medicine and Health Sciences.

Academic career Jan De Maeseneer is involved in undergraduate and postgraduate teaching, training and research. He actually chairs the Educational Committee (since 1997) in charge of a fundamental reform of the undergraduate curriculum (from a discipline-based towards an integrated patient-based approach). This new curriculum has been evaluated very positively by an international Accreditation Board and has been awarded in 2005 a special quality award for its community orientation and social accountability. He is board member of the Interuniversity Flemish Consortium for vocational training of family medicine and he chairs the working party for family medicine of the Belgian High Council for medical specialists and family physicians (1998). In 2004 Prof. De Maeseneer received the "WONCA-award for excellence in health care: the Five-Star Doctor" at the 17th World Conference of Family Doctors in Orlando (USA). In 2008 he received a "Doctor Honoris Causa" degree at the Universidad Mayor de San Simon in Cochabamba (Bolivia). In 2010, he received the prize De Schaepdrijver-Caenepeel for developmental work from the Royal Flemish Academy of Medicine. In 2012 he was offered the title of Honorary Professor in the Centre for Primary Care and Public Health in Blizard Institute within Queen Mary, University of London. In 2014 he received the Special Award for Excellence in Health Professional Education at the Prince Mahidol Award Conference in Thailand.

Research The research activities are focused on: epidemiology of general practice, functioning of GPs, prescription behaviour, medical decision making, medical education, health systems research, equity in health care, telematics in health care, health outcome and health and poverty. He wrote articles in several journals on health education, epidemiology, medical decision making, medical education, quality of care, community oriented primary care, interdisciplinary team work, training in general practice, health and poverty, health in developing countries. Prof. De Maeseneer is the author of more than 150 scientific publications. More than 100 of them have been published in international journals with peer review-system. He also has given many lectures at international and national conferences. Since 1996 he is a member of the editorial board of the “European Journal of General Practice” and of the WICC (Wonca International Classification Committee). Prof. De Maeseneer is chairman of the European Forum for Primary Care since 2005 (www.euprimarycare.org). Since October 2010 he is Director of the International Centre for Primary Health Care and Family Medicine – Ghent University, that has been designated as a WHO Collaborating Centre on PHC. Since 2012 he is a member of the Global Forum on innovation of Health Professionals’education at the National Academies of Sciences, Engineering and Medicine (Washington).

Social accountability In 1990-1991, he has been advisor on primary health care of the federal Minister of Health. Since 2010, he is the Chairman of the Strategic Advisory Board of the Flemish Minister for Welfare, Health and Family. He has been member of the Advisory Committee on Medical Training of the EU and of the Scientific Advisory Board of the "Organisation for Accreditation and Quality Assurance" in Switzerland. From 2006 to 2008, Prof. J. De Maeseneer was a member of the Knowledge Network on "Health System" of the WHO Commission on Social Determinants of Health. He actually is a member of the Scientific Committee for the Renewal of Primary Health Care of WHO-Geneva. He has been the Chairman of the Expert Panel on Effective Ways of Investing in Health (EXPH), advising the European Commission from 2013 until 2016.

International cooperation Prof. De Maeseneer has been involved in the development of various programs of international cooperation and student exchange (University of Cochabamba in Bolivia, University of Cape Town in South Africa, University Yaounde I in Cameroon, University of Makerere in Kampala, University of Science and Technology in Mbarara – Uganda, University of Cuenca – Ecuador and Pontifica Universidad Catolica de Ecuador - Quito). He is promoter of the VLIR-Own Initiatives project on "Optimisation of family medicine training in Southern and Eastern Africa" that has an important impact on the development of primary health care. He is promotor of the Primafamed-network (www.primafamed.ugent.be). From 2007 - 2015, Jan De Maeseneer has been the Secretary General of the Network "Towards Unity for Health" (www.the-networktufh.org).

Languages: Dutch, English, French, German, Spanish.
Mr. Yannis Natsis

Mr. Yannis Natsis

Policy Coordinator Universal Access and Affordable Medicines, EPHA

Yannis joined the European Public Health Alliance (EPHA) in January 2016 as the Policy Coordinator on Universal Access and Affordable Medicines. He follows closely the regulatory developments in the field of medicines, issues of medical innovation and access of patients to their treatments. He is committed to promoting transparency and public scrutiny of EU decision-making and believes strongly in a public-interest pharmaceutical model. He has worked at the European Parliament, the Greek Ministry of Foreign Affairs, the UN and the private sector in Brussels and Athens. Between 2013-2015, Yannis served as the Advocacy Advisor on access to medicines and access to knowledge for the TransAtlantic Consumer Dialogue (TACD). Yannis is a Greek national, fluent in Greek, English and French.
Dr Marc Van De Casteele, MD PhD

Dr Marc Van De Casteele, MD PhD

Coordinator of pharmaceutical assessment Belgian Institute for Health Insurance and Invalidity

Dr Marc Van De Casteele is internist-hepatologist. Since 2003, he is a pharmaceutical expert working for the Commission of Reimbursement of Pharmaceuticals. Since 2013, he is the coordinator of the pharmaceutical assessment for the Commission. This Commission gathers at the Department of Pharmaceutical Policy (general councilor: Francis Arickx) of the Belgian Institute for Health Insurance and Invalidity in Brussels (Director General Health Care: Ri De Ridder). The Commission advises the Belgian Minister on applications of reimbursement of pharmaceuticals. Dr Marc VAN DE CASTEELE is involved in EUnetHTA, the Network of Health Technology Assessment and Medev. He is visiting professor of hepatology at the University of Leuven (Belgium).
Zoltán Kaló

Zoltán Kaló

Head of the Institute of Economics at Eötvös Loránd University (ELTE) in Budapest

Zoltán Kaló is a Professor of Health Economics and Head of the Institute of Economics at Eötvös Loránd University (ELTE) in Budapest. He is the co-director of the Health Policy, Planning and Financing master program (in Englsih). Dr. Kaló is also the founder and leader of Syreon Research Institute, an international research corporation specializing in health policy, health economic modeling and technology assessment.

He received Bachelor of Economics degree from the Budapest University of Economics; Medical Doctor degree from the Semmelweis Medical University; MSc in Health Economics degree from the University of York; PhD in Pharmaceutical Sciences degree from the Semmelweis University; and DrHabil degree in Sociology from the ELTE University.

He has 20 years of international experience in academia and industry, specializing in health systems design, HTA implementation, health economics and outcomes research, economic modeling, patient access and pricing policies of healthcare technologies.

Dr. Kaló serves as a policy advisor to public decision-makers and global health care corporations. He was a Director of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) between 2012-2014, and the Chair of ISPOR Central and Eastern European Network Executive Committee between 2013-2015.

Selected list publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=kalo+z
Dávid Dankó, PhD

Dávid Dankó, PhD

Managing director, Ideas & Solutions (I&S)

Dávid Dankó is managing partner of Ideas & Solutions (I&S), an independent research and consultancy firm which provides health policy and market access advisory services to pharma and medical device companies with a focus on emerging and middle-income markets. He also holds a position as research leader at the Corvinus University of Budapest, Hungary, where he lectures pharmaceutical policy and funding.

Dávid has 13 years of experience in health care management & the funding of pharmaceuticals and medical devices. Until 2010 he was member of the executive team for pharmaceutical reform in Hungary as deputy director of reimbursement at the national health insurance fund. He speaks regularly at conferences and workshops on pharmaceutical and medical device policies, gives payer communication and negotiation trainings to multinational companies and authorities and he has co-edited a university textbook titled ‘Pharmaceutical Reimbursement’.

Focuses:
  • Pragmatic value assessment and HTA systems for middle-income markets
  • Process and data transparency of pharmaceutical decision-making processes
  • Linking managed entry agreements to value assessment of pharmaceuticals
  • Negotiations and communication with payers and other governmental stakeholders
  • Alternative funding strategies for middle and low-income countries


Dávid has lectured at the European Market Access University Diploma (EMAUD) programme, the Semmelweis University of Budapest, Debrecen University, Eötvös Loránd University and the former Vienna School of Clinical Research. He graduated in Economics from Corvinus University of Budapest and earned a PhD degree in 2012 with his thesis on resource management in pharmaceutical research & development.
Mariya Samuilova

Mariya Samuilova

Project officer, Migration Health Division, International Organization for Migration

Mariya Samuilova is a Project Officer at Migration Health Division (MHD), IOM. Under the direct supervision of the Senior Regional Migration Health Advisor, European region, she is responsible for the development, coordination and implementation of projects and liaison to the EU institutions on migration health. She has more than 10 years’ experience in research and social policy analysis including more than 8 years in the field of migration and health in Europe. Mariya joined MHD in 2008, as a researcher and also later as a coordinator of different EU projects, implemented and/or partnered by IOM. Currently she coordinates the implementation of the Equi-Health project, a direct grant agreement between IOM and DG SANTE (2012-2016) and other MHD RO Brussels led projects.
Mr. Denis Horgan

Mr. Denis Horgan

Executive Director of the European Alliance for Personalised Medicine (EAPM)

Denis Horgan is the Executive Director of the European Alliance for Personalised Medicine (EAPM). Horgan has extensive expertise in health policy and issue advocacy. Before working with the EAPM, he worked with the European Cancer Patient Coalition and in the European Parliament on a broad array of health issues and in international NGOs on health development projects in Afghanistan, Mexico and Palestine. Over the course of his career, Horgan has developed public affairs initiatives in the areas of advocacy, social marketing, policy support and launch, policy development and media relations. As a senior policy affairs manager, he has actively been involved in coalition building, grassroots advocacy, conference development and development of policy platforms to support access to reimbursement and treatment at the political level and with institutions and bodies.
Artur Carvalho

Artur Carvalho

European Commission, DG Health and Food Safety, Unit B1- Performance of national health systems

Artur Carvalho works at the European Commission since 2010 and at DG Health and Food Safety since 2012. He graduated in Economics in 1999 and was awarded a Master in European Economics in 2007, in both cases from the Coimbra University (Portugal). Before joining the European Commission he worked as Executive Director of a Science Park and as Economist and Executive Director in a Regional Development Agency. He taught Enterprise Economics and Financial Accounting in Portuguese Universities. He has lived in Portugal, Italy, Brazil and Belgium.
Anders Olauson

Anders Olauson

Chairperson of the Patient Access Partnership (PACT) and an Honorary President of the European Patients’ Forum (EPF)

Anders Olauson was involved in the founding of the Agrenska Centre in 1989. He served as director until 2004 and since then has been chairman. He is responsible for establishing The Agrenska Virtual International Academy, a research centre for rare disorders. In 2003 The Eesti Agrenska Foundation was inaugurated, and Anders is serving as Chairman of the Council since then.

Anders is past member of the board of Eurordis, and was president from 1999 to 2001. He represented it as a member of the board of the European Patients’ Forum (EPF) until 2016. He has been president of EPF since June 2005 until 2016, when he was appointed Honorary President for EPF. Anders represents EPF in steering committees, which has been established by DG Sanco and DG Infso.

Between 2006 and 2012, Anders was a member of the advisory group for Health Research within DG Research. Since 2013/14, Anders is appointed member of the Horizon 2020 Advisory group for Societal Challenge - Configuration 'Health, demographic change and well-being’.

In 2005, Anders was accepted as a researcher within the PhD program at Gothenburg University. The Swedish Government appointed Anders to serve as a member of the Advisory Council at The National Board of Health and Welfare from 2008 - 2014.

Anders Olauson received HM The King of Sweden’s Medal for his valuable contributions in the field of disability. Anders was presented with the King’s medal 8th size, with the Seraphim Ribbon at the Royal Palace in Stockholm, the 28th of January 2010.
ANNABEL SEEBOHM LL.M.

ANNABEL SEEBOHM LL.M.

Secretary General of the Standing Committee of European Doctors (CPME)

Annabel Seebohm is the Secretary General of the Standing Committee of European Doctors (CPME). Prior to joining CPME in May 2016, Annabel worked as head of the Brussels office and legal advisor of the German Medical Association (GMA). From 2007 to 2016 she was also legal advisor of the World Medical Association (WMA). Annabel studied law at the University of Bonn, undertook her judicial service training in Hamburg and holds a Masters degree from the University of Auckland, New Zealand. She is admitted to the Berlin Bar.
Richard Bergstrӧm

Richard Bergstrӧm

Director General, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)

Richard Bergström has been the Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) since April 2011. Previously he served for nine years as the Director-General of LIF, the Swedish Association of the Pharmaceutical Industry, following positions in Switzerland in regulatory affairs at the pharmaceutical companies Roche and Novartis. Mr. Bergström has also been appointed by the Swedish Government to the Board of the Karolinska Institute. He is a pharmacist by training, receiving his MScPharm degree from the University of Uppsala, Sweden in 1988.
Adrian van den Hoven

Adrian van den Hoven

Director General, Medicines for Europe

Adrian van den Hoven was appointed Director General of the Medicines for Europe (formerly European Generic and Biosimilar Medicines Association - EGA) on 1 September 2013. Before this he was Deputy Director General of BUSINESSEUROPE with responsibility for the International Relations and Industry departments. He worked as an International Relations researcher and adjunct professor in Italy (EUI), France (Nice) and Canada (Windsor) prior to joining BUSINESSEUROPE in 2003. He received his doctorate in Political Science from the University of Nice, France in 2000.
Dr. Dominik Tomek, PharmD., PhD., MPH

Dr. Dominik Tomek, PharmD., PhD., MPH

Founding member of the Slovak Society for Pharmacoeconomics, Slovak Agency for Health Technology Assessment and a founding member and the current president of ISPOR Chapter Slovakia

Dr. Dominik Tomek, PharmD., PhD., MPH, 1956, has experience in public and hospital pharmacies, government administration and regulatory agency incl. oncology hospital, Ministry of Health and Health Insurance. He is a founding member of the Slovak Society for Pharmacoeconomics, Slovak Agency for Health Technology Assessment and a founding member and the current president of ISPOR Chapter Slovakia. He was elected as director in the ISPOR Board of Directors for the term 2014 – 2016 and board member of ISPOR CEE Network.

Dr. Tomek served for many years in the Drug Committee of State Institute for Drug Control, Pricing Committee of Ministry of Finance and Reimbursement Committee of Ministry of Health. He is teaching at the Faculty of Medicine, Slovak medical university, Bratislava, Slovakia. Dr. Tomek has a doctor degree in Clinical Pharmacy, a PhD. in the field of public health and degrees of postgraduate specializations in management of public pharmacy, preparation of radiopharmaceuticals, and revision pharmacy for health insurance, pharmacoeconomics, in management of public health and in market access. He studied Market Access at the University of Lyon with Prof. Mondher Toumi in EMAUD class.

He pioneered Patient Empowerment and patient education in Slovakia. Since 2010 he is teaching, training and lecturing patients in the field of treatment adherence, prevention, communication, health economy and other drug policy and health policy issues. He initiated patient education on the Faculty of Medicine, where he is supervising this education. As a patient himself, a patient relative and a long time health care provider, is he a dedicated patient advocate. He is vice president and scientific advisor to the Association for the Protection of Patient Rights in Slovak republic and Board Member of the European Patients Forum in Brussels.




 

REGISTRATION

Registration is closed!

OUR VENUE


VENUE INFO

Hotel Marinela
1407 Sofia
James Bourchier Boulevard 100

http://www.hotel-marinela.com/

CONTACT US

mobile: +359 / 879 44 99 81
mobile: +359 / 879 44 99 84
e-mail: [email protected]

 



TRANSPORTATION AND DIRECTIONS

The hotel is located in the green area of Sofia, close to the city center. Hotel Marinela is one of the landmarks of the city.

PACT will be providing transfers from and to the airport (upon prior notification by the organisers). Alternatively, you can arrive by using one of the following options:


By metro (Terminal 2 - Hotel Marinela):
Take M1 from “Sofia Airport” station to “Serdika” station. Change to M2 (direction “Vitosha” station) to “James Bourchier” station. Exit towards “Zlaten rog” Street. Take the right through the park until you reach Hotel Marinela (about 200 m.).


By car:
GPS coordinates (Latitude: N 42.6978 / 42°42'52; Longitude: E 23.3217 / 23°20'18)


By taxi:
For your comfort and safety, we recommend the services of the taxi operator OK Supertrans AD as contractual partner of Sofia Airport.

You can request the service at the offices of OK Supertrans in the Arrivals of Terminal 1 and Terminal 2 (+359 2 973 2121; www.oktaxi.net). The floor markings in yellow will lead you to the taxi stand area.

We recommend that you do not use taxi services offered outside the office of the taxi operator or in front of the terminal to avoid the risk of abuse.